Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115088 · ClinicalTrials.gov registry record · NA

Effects of Stevia on Satiety and Eating Attitudes in Healthy, Overweight and Obese Adults

A NA study, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01115088: Completed NA study, sponsored by Pennington Biomedical Research Center.

NCT01115088 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01115088, a NA study, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to test the effects that three different types of sweeteners have on food intake, hunger and satiety levels, as well as insulin and glucose measures. The study of whether food or beverages containing Stevia influence food intake to a greater extent than food or beverages sweetened with Aspartame or Sucrose. Also, examining whether taste preference and taste sensitivity influence food intake.

Primary Outcome

Test whether preloads of tea and crackers with cream cheese sweetened with Stevia lover postprandial insulin levels compared to preloads of tea and crackers with cream cheese sweetened with Sucrose or Aspartame by measuring blood insulin and glucose levels immediately prior to the lunch preload,immediately before lunch test meal, and at thirty minutes, one hour, and two hours after the lunch test meal.

Interventions

  • DIETARY_SUPPLEMENT Sucrose
  • DIETARY_SUPPLEMENT Aspartame
  • DIETARY_SUPPLEMENT Stevia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-01
Est. Completion 2010-04
Phase NA

What the finished NCT01115088 record still lists

NCT01115088 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Sucrose is the first listed.

NCT01115088 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01115088 about?

NCT01115088 is a clinical study titled "Effects of Stevia on Satiety and Eating Attitudes in Healthy, Overweight and Obese Adults". The purpose of this study is to test the effects that three different types of sweeteners have on food intake, hunger and satiety levels, as well as insulin and glucose measures. The study of whether food or beverages containing Stevia influence food intake to a greater extent than food or beverages...

What is the current status of trial NCT01115088?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-01. Estimated completion is 2010-04.

What interventions are being tested in trial NCT01115088?

The interventions under investigation include: Sucrose (DIETARY_SUPPLEMENT), Aspartame (DIETARY_SUPPLEMENT), Stevia (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01115088?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01115088's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01115088, the US trial registry maintained by the National Library of Medicine. NCT01115088 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.